[Federal Register Volume 69, Number 102 (Wednesday, May 26, 2004)]
[Notices]
[Page 29979]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 04-11820]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Sec.  1301.33(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on March 17, 2004, Boehringer 
Ingelheim Chemicals Inc., 2820 N. Normandy Drive, Petersburg, Virginia 
23805, made application by renewal to the Drug Enforcement 
Administration (DEA) for registration as a bulk manufacturer of the 
basic classes of controlled substances listed below.

------------------------------------------------------------------------
                            Drug                               Schedule
------------------------------------------------------------------------
Amphetamine (1100)..........................................         II
Methylphenidate (1724)......................................         II
Methadone (9250)............................................         II
Methadone Intermediate (9254)...............................         II
Dextropropoxyphene, bulk (non-dosage forms) (9273)..........         II
Levo-alphacetylmethadol (9648)..............................         II
Fentanyl (9801).............................................         II
------------------------------------------------------------------------

    The firm plans to manufacture the listed controlled substances for 
formulation into finished pharmaceuticals.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such substance may file comments or objections 
to the issuance of the proposed registration.
    Any such comments or objections may be addressed, in quintuplicate, 
to the Deputy Assistant Administrator, Office of Diversion Control, 
Drug Enforcement Administration, United States Department of Justice, 
Washington, DC 20537, Attention: Federal Register Representative, 
Office of Chief Counsel (CCD) and must be filed no later than July 26, 
2004.

    Dated: May 5, 2004.
William J. Walker,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 04-11820 Filed 5-25-04; 8:45 am]
BILLING CODE 4410-09-M